Poznaj
- Poznaj
  Poznaj terapie genowe i komórkowe
- Educational Resources Directory
  Educational Resources Directory
- INTENS
  INtestinal Tissue ENgineering Solution
- LEARN
  Listening to the experience of participants in neurosurgical trials
Poznaj terapie genowe i komórkowe
Research Pathways
- Research Pathways
  Bringing new therapies from the lab to patients
- Badania
  Nowe terapie - od laboratorium do pacjentów
- ATMP Engage
  Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
- Actors and Network database
  Actors and Networks database
Bringing new therapies from the lab to patients
O nas
Nasz zespół i partnerzy
Kontakt

Choroby

Choroba Alzheimera
Choroba Huntingtona
Choroba neuronu ruchowego
Choroba Parkinsona
Choroby immunologiczne
Choroby krwi
Choroby nerek
Choroby neurologiczne
Choroby oczu
Choroby płuc
Choroby rzadkie
Choroby serca
Choroby układu mięśniowo-szkieletowego
Choroby wątroby
Cukrzyca
Dystrofia mięśniowa
Krew pępowinowa
Mózgowe porażenie dziecięce
Pęcherzowe oddzielanie się naskórka
Rak
Rdzeniowy zanik mięśni
Skóra
Stwardnienie rozsiane
Udar
Urazy rdzenia kręgowego
Zapalenie jelit
Płodność

Tematy

Badania
Etyka i społeczeństwo
Fakty
Inżynieria tkankowa
Komórki iPS
Komórki macierzyste krwi
Komórki macierzyste skóry
Krew pępowinowa
Metody i narzędzia
Modyfikowanie genów
MSC
Nowinki o komórkach macierzystych
Obecne i potencjalne wykorzystanie
Organoidy
Podstawowe informacje o komórkach i genach
Polityka i regulacje prawne
Poznaj komórki macierzyste
Poznawanie chorób
Próby kliniczne
Przemysł
Reprogramowanie
Terapia CAR-T
Terapia genowa
Terapia komórkowa
Terapie przed zatwierdzeniem
Udział pacjentów
Zarodkowe komórki macierzyste

Wybierz język

English
Français
Deutsch
Italiano
Polski
Español
Português

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

Nawigacja okruszkowa/Nawigacja breadcrumb

ATMP Engage
PPI Directory

PPI Directory

Title

PPI Themes

PPI Themes
- PPI Basics and Benefits
- Standards for PPI
- Roles and Responsibilities
- PPI Pools/Lists of Organisations
- Knowledge Building
- Strategies/Statements/Policies on PPI
- Budgeting/Compensation
- Project Planning
- How/Who to Recruit
- Using Technology
- Training
- Maintaining/Supporting PPI
- Communication/Plain Language/Glossaries
- Case Studies
- Evaluating/Recording PPI Impact
- Feedback to/from PPI

Research Field

Research Field
- General
- Biomedical Lab
- Pharmaceutical
- ATMP/Gene Therapy Development
- Other

Organisation Type

Organisation Type
- Funder
- Academia
- Healthcare
- Regulatory Body
- HTA
- Industry
- Third Sector/Charity
- Other Organisation

Development Stage

Development Stage
- Identifying/Prioritising Patient Need
- Research and Clinical Development
- Regulatory Approval
- Health Technology Assessment
- Service Delivery

Audience

Audience
- Researchers/Developers
- Public/Patients
- Charity Sector
- Industry
- Other groups

Country

Country
- UK
- Europe
- North America
- Other countries

Content Type

Content Type
- Resource
- Journal
- Repository
- Article

toolkit
partnership
NHS

Knowledge Building✕
Standards for PPI✕

Showing 5 of 83 results.

Page 8 of 17

2020

EMA Regulatory Science to 2025 - strategic reflection

Report reflecting on the EMA's regulatory framework by the European Medicines Agency

View this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Researchers/Developers
Public/Patients

Country

Europe

Content Type

Resource

Advanced Therapy Classification

Classification of ATMPs by the European Medicines Agency

Visit this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Regulatory Body

Audience

Researchers/Developers
Public/Patients
Charity Sector
Industry
Other groups

Country

Europe

Content Type

Resource

2018

Guideline on safety and efficacy follow up and risk management of ATMPs

Report on guidance on long term follow up for ATMPs by the European Medicines Agency

View this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Researchers/Developers

Country

Europe

Content Type

Resource

2018

Procedural advice on the evaluation of advanced therapy medicinal product in accordance with Article 8 of Regulation (EC) No 1394/2007

Document outlining the procedure on ATMP evaluation by European Medicines Agency

View this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Researchers/Developers

Country

Europe

Content Type

Resource

2019

Patients' and consumers' working party

Patient' and Consumers' Working Party meeting notes and objectives published by the European Medicines Agency (EMA)

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Researchers/Developers
Public/Patients
Charity Sector
Industry
Other groups

Country

Europe

Content Type

Resource

Pagination

First page
Previous page
…
Strona 6
Strona 7
Strona 8
Strona 9
Strona 10
…
Next page
Last page

Who are we?

The Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group (ATMP Engage) brings together UK-based stakeholders with an interest in ATMPs to discuss and collaborate on PPIE activity.

Learn more about ATMP Engage

Powrót do góry strony

Footer menu

Warunki
Prywatność
Dostępność
Skontaktuj się z nami

EuroGCT na Facebooku EuroGCT na Twitterze